Journal of Clinical Epidemiology
Volume 53, Issue 1 , Pages 13-17 , January 2000

Ready, set, stop Reflections on assessing quality of life and the WHOQOL-100 (U.S. version)

  • J.Ivan Williams

      Affiliations

    • Institute of Clinical Evaluative Sciences University of Toronto, Department of Family & Community Medicine, Department of Public Health Sciences, Graduate Departments of Nursing Science, Rehabilitation Science & Institute of Medical Science, Toronto, Ontario, Canada
    • Clinical Epidemiology and Health Care Research Program, Sunnybrook and Women's College Heath Sciences Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel: 416-480-4055; Fax: 416-480-6048. E-mail address:(J.I. Williams)

Received 4 May 1999 ,Accepted 1 June 1999.

References 

  1. Spilker B. Quality of Life and Pharamaeconomics in Clinical Trials. 2nd Ed. Philadelphia: Lippincott-Raven; 1996;
  2. McDowell I, Newell C. Measuring Health (a Guide to Rating Scales and Questionnaires). 2nd Ed. New York: Oxford University Press; 1996;
  3. Bowling A. Measuring Disease (a Review of Disease-Specific Quality of Life Measurement Scales). Philadelphia: Open University Press; 1995;
  4. Bowling A. Measuring Health (A Review of Life Measurement Scales). 2nd Ed. Philadelphia: Open University Press; 1997;
  5. Szabo S, on behalf of the WHOQOL Group. The World Health Organization Quality of Life (WHOQOL) assessment instrument. In: Spilker B, editor. Quality of Life and Pharmaeconomics in Clinical Trials. 2nd Ed. Philadelphia: Lippincott-Raven, 1996. pp. 355–62.
  6. WHOQOL Group . The World Health Organization Quality of Life assessment (WHOQOL) (position paper from the World Health Organization). Soc Sci Med. 1995;10:1403–1409
  7. WHOQOL Group . The World Health Organization Quality of Life assessment (WHOQOL) (Development and general psychometric properties). Soc Sci Med. 1998;12:1569–1585
  8. Bullinger M, Power MJ, Aaronson NK, Cella DF, Anderson RT. Creating and evaluating cross-cultural instruments. In:  Spilker B editors. Quality of Life and Pharmaeconomics in Clinical Trials. 2nd Ed. Philadelphia: Lippincott-Raven; 1996;
  9. Bonomi AE, Patrick DL, Bushnell DM, Martin M. Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol. 1999;52:13–17
  10. Ware JE, Sherbourne CD, The MOS 36-Item Short-Form Health Survey (SF-36) . I (conceptual framework and item selection). Med Care. 1992;30:473–483
  11. McHorney CA, Haley SM, Ware JE. Evaluation of the MOS SF-36 physical functioning scale (PF-10). II (comparison of relative precision using Likert and Rasch scoring methods). Med Care. 1992;31:247–263
  12. McHorney CA, Ware JE, Rogers WH, Raczek AE, Lu JFR. The MOS 36-Item Short-Form Health Survey (SF-36). III (tests of data quality, scaling assumptions and reliability across diverse patient groups). Med Care. 1994;32:40–66
  13. Medical Outcomes Trust Scientific Advisory Committee Instrument Review Criteria. MOT Bulletin: I–V 1995. Boston: MOT Committee.
  14. Gerin P, Dazord A, Boissel J, Chifflet R. Quality of life assessment in therapeutic trials (Rationale for and presentation of a more appropriate instrument). Fundam Clin Pharmacol. 1992;6:263–276
  15. Dazord A, Terra JL, Manificat S, et al.  A new French instrument to evaluate patient's quality of life (first results). Qual Life Res. 1994;3:41
  16. Dazord A, Leizorovicz A, Gerin P, Boissel JP. Quality of life of patients during treatment of type I diabetes. Importance of a questionnaire focused on the subjective quality of life. Diabetes Metab. 1994;20:465–472
  17. Nunnally JC. Psychometric Theory. 2nd Ed. New York: McGraw-Hill; 1998;
  18. Meier ST. The Chronic Crisis in Psychological Measurement and Assessment (A Historical Survey). San Diego: Academic Press; 1994;
  19. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley; 1986;
  20. Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1987;
  21. Williams JI, Naylor CD. How should health status measures be assessed? Cautionary notes on procrustean frameworks. J Clin Epidemiol. 1992;45:1347–1351
  22. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice (are available health status surveys adequate?). Qual Life Res. 1995;4:298–307
  23. Cohen J. Statistical Power Analysis for the Behavioural Sciences. 2nd Ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988;
  24. McHorney CA. Generic health measurement (past accomplishments and a measurement paradigm for the 21st century). Ann Intern Med. 1997;127:666–674
  25. Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, et al.  Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries (results from the IQOLA Project). J Clin Epidemiol. 1998;51:1203–1214
  26. Haley SM, McHorney CA, Ware JE. Unidimensionality and reproducibility of the Rasch item scale. J Clin Epidemiol. 1994;47:671–684
  27. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. J Am Med Assoc. 1994;272:619–626
  28. Murawski MM, Miederhoff PA. On the generalizability of statistical expressions of health related quality of life instrument responsiveness (a data synthesis). Qual Life Res. 1998;7:11–12
  29. Kessler RC, Morczek DK. Some methodological issues in the development of quality of life measures for the evaluation of medical interventions. J Eval Clin Pract. 1996;2:181–191
  30. Williams JI. Time, space, and motion (the unanswered questions in measuring quality of life). Can J Nurs Res. 1998;30:119–124
  31. McDowell I, Jenkinson C. Developing standards for health measures. J Health Serv Res Pol. 1996;4(1):238–246

PII: S0895-4356(99)00122-5

Journal of Clinical Epidemiology
Volume 53, Issue 1 , Pages 13-17 , January 2000

Article Tools